Human cell programming company bit.bio has secured $25million in Series D funding to expand its portfolio of human cell models andincrease access to its technology for pharmaceutical companies, biotec…
This is a summary
The full article is published by Tech.eu. We hold only a headline and a short summary here.
Read the full article